Goldman Sachs’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-24,166	Closed	-$8K	–	6731
2017 Q4	$8K	Buy	+24,166	New	+$8.23K	﹤0.01%	6226
2016 Q4	–	Sell	-1,294	Closed	-$6K	–	7340
2016 Q3	$6K	Sell	1,294 -640	-33%	-$4.12K	﹤0.01%	6921
2016 Q2	$18K	Buy	1,934 +1,214	+169%	+$12.5K	﹤0.01%	6757
2016 Q1	$8K	Buy	720 +245	+52%	+$2.76K	﹤0.01%	6938
2015 Q4	$7K	Hold	475	–	–	﹤0.01%	7026
2015 Q3	$8K	Sell	475 -133	-22%	-$2.42K	﹤0.01%	7172
2015 Q2	$11K	Buy	608 +129	+27%	+$2.48K	﹤0.01%	7154
2015 Q1	$9K	Buy	479 +3	+0.6%	+$75	﹤0.01%	6982
2014 Q4	$14K	Hold	476	–	–	﹤0.01%	7020
2014 Q3	$17K	Sell	476 -1	-0.2%	-$39	﹤0.01%	7005
2014 Q2	$21K	Sell	477 -27	-5%	-$1.3K	﹤0.01%	6875
2014 Q1	$25K	Buy	504 +50	+11%	+$2.44K	﹤0.01%	6666
2013 Q4	$17K	Sell	454 -5,364	-92%	-$508K	﹤0.01%	6551
2013 Q3	$598K	Sell	5,818 -6,264	-52%	-$688K	﹤0.01%	5024
2013 Q2	$938K	Buy	+12,082	New	+$1.16M	﹤0.01%	4450